BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1066352)

  • 1. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Humoral immunity in human sarcomas].
    Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
    Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell mediated immunity in osteogenic sarcoma. Role of the regional lymph nodes.
    Rao RS; Agashe SS; Nair PN; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):56-60. PubMed ID: 1058831
    [No Abstract]   [Full Text] [Related]  

  • 7. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs.
    Brodey RS; Fidler IJ; Bech-Nielsen S
    Am J Vet Res; 1975 Jan; 36(1):75-80. PubMed ID: 1054221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postoperative studies of in vitro cell-mediated reactivity in canine osteosarcoma.
    Bech-Nielsen S; Reif JS; Brodey RS
    Am J Vet Res; 1978 Jan; 39(1):87-93. PubMed ID: 272858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of virus-induced rat osteosarcoma.
    Urovitz EP; Czitrom AA; Langer F; Gross AE; Pritzker PH
    J Bone Joint Surg Am; 1976 Apr; 58(3):308-11. PubMed ID: 1063128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The host immune response in human osteosarcoma.
    McMaster JH; Ferguson RJ; Weinert CR
    Clin Orthop Relat Res; 1975 Sep; (111):76-82. PubMed ID: 1057466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function tests during adjuvant lung irradiation for osteogenic sarcoma.
    Carcelen A; Zaharia M; Caceres E; Moran M; Tejada F
    Cancer Treat Rep; 1980; 64(4-5):701-03. PubMed ID: 6933006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose fractionation in photon and neutron therapy in the combined treatment of osteogenic sarcoma].
    Musabaeva LI; Lantsman IuV; Lisin VA; Modiaev VP; Maritskiĭ SV; Vaks KP
    Med Radiol (Mosk); 1990 Apr; 35(4):27-32. PubMed ID: 2336007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.